fda semaglutide shortage lawsuit Ofa Compounded Novo Nordisk expands legal action

Research-grade lyophilized peptide

The FDA stopped short of saying the potentially life-threatening condition was caused by the drugs, which have become popular for weight loss.

Additionally, it helps reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and elevated body weight

Experts are studying the use of GLP-1 medications to manage rheumatoid arthritis

An initial view into the growing popularity and usage of GLP-1 medications for weight loss and the resulting impact on consumer shopping behavior.

DPP IV was chosen as a template to employ molecular docking via Discovery Studio to search for natural phenolic compounds whether they have the inhibitory function of DPP IV